Cargando…

Glycogen Synthase Kinase 3 Regulates Cell Death and Survival Signaling in Tumor Cells under Redox Stress()

Targeting tumor-specific metabolic adaptations is a promising anticancer strategy when tumor defense mechanisms are restrained. Here, we show that redox-modulating drugs including the retinoid N-(4-hydroxyphenyl)retinamide (4HPR), the synthetic triterpenoid bardoxolone (2-cyano-3,12-dioxooleana-1,9(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venè, Roberta, Cardinali, Barbara, Arena, Giuseppe, Ferrari, Nicoletta, Benelli, Roberto, Minghelli, Simona, Poggi, Alessandro, Noonan, Douglas M., Albini, Adriana, Tosetti, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234881/ https://www.ncbi.nlm.nih.gov/pubmed/25246272 http://dx.doi.org/10.1016/j.neo.2014.07.012

Ejemplares similares

Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation
por: Venè, Roberta, et al.
Publicado: (2015)

Human Gut-Associated Natural Killer Cells in Health and Disease
por: Poggi, Alessandro, et al.
Publicado: (2019)

The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3β pathway and β-catenin stability
por: Benelli, Roberto, et al.
Publicado: (2010)

Regulation of angiogenesis by angiostatin through immune cells and IL 12 production
por: Noonan, Douglas M, et al.
Publicado: (2006)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy
por: Venè, Roberta, et al.
Publicado: (2020)

Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells
por: Tosetti, Francesca, et al.
Publicado: (2018)

Inflammatory angiogenesis as a target for prevention and therapy: Kaposi's sarcoma and HIV tat as models
por: Albini, Adriana, et al.
Publicado: (2006)

SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation
por: Costa, Delfina, et al.
Publicado: (2023)

Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts
por: Costa, Delfina, et al.
Publicado: (2018)

Interactomes of Glycogen Synthase Kinase-3 Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023)

Regulation by Glycogen Synthase Kinase-3 of Inflammation and T Cells in CNS Diseases
por: Beurel, Eléonore
Publicado: (2011)

Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
por: Piazza, Francesco, et al.
Publicado: (2010)

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

Regulation of Cell Survival Mechanisms in Alzheimer's Disease by Glycogen Synthase Kinase-3
por: Mines, Marjelo A., et al.
Publicado: (2011)

Pharmacological Inhibition of Glycogen Synthase Kinase 3 Regulates T Cell Development In Vitro
por: Schroeder, Jan-Hendrik, et al.
Publicado: (2013)

Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism
por: Pereira, Marcelo S. F., et al.
Publicado: (2023)

Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
por: Jope, Richard Scott
Publicado: (2011)

Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission
por: Polter, Abigail M., et al.
Publicado: (2011)

Glycogen Synthase Kinase-3 Is Required for Efficient Dictyostelium Chemotaxis
por: Teo, Regina, et al.
Publicado: (2010)

The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons
por: Zhou, Wenjun, et al.
Publicado: (2012)

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020)

Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases
por: Marosi, Mate, et al.
Publicado: (2022)

The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
por: Yu, Honglu, et al.
Publicado: (2023)

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
por: Bilim, V, et al.
Publicado: (2009)

Correction: Pharmacological Inhibition of Glycogen Synthase Kinase 3 Regulates T Cell Development In Vitro
por: Schroeder, Jan-Hendrik, et al.
Publicado: (2013)

Polarized Regulation of Glycogen Synthase Kinase-3β Is Important for Glioma Cell Invasion
por: Zou, Qifei, et al.
Publicado: (2013)

The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil
por: Xu, Jing, et al.
Publicado: (2013)

Glycogen Synthase Kinase 3 Regulates the Genesis of Displaced Retinal Ganglion Cells3
por: Kisseleff, Elena, et al.
Publicado: (2021)

Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cells
por: Taylor, Alison, et al.
Publicado: (2020)

The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury
por: Li, Changbin, et al.
Publicado: (2015)

Underlying mechanisms of glucocorticoid-induced β-cell death and dysfunction: a new role for glycogen synthase kinase 3
por: Delangre, Etienne, et al.
Publicado: (2021)

Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis
por: Mamaghani, Shadi, et al.
Publicado: (2012)

Aberrant spindle dynamics and cytokinesis in Dictyostelium discoideum cells that lack glycogen synthase kinase 3()
por: Harwood, Adrian J., et al.
Publicado: (2013)

Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells
por: Santha, Sreevidya, et al.
Publicado: (2016)

Glycogen Synthase Kinase-3 (GSK-3) Regulation of Inhibitory Coreceptor Expression in T-cell Immunity
por: Issa, Mark E., et al.
Publicado: (2021)

Antidiabetic and vasoprotective activity of lithium: Role of glycogen synthase kinase-3
por: Kanzariya, Nilesh R., et al.
Publicado: (2011)

Functional Implications of Glycogen Synthase Kinase-3-Mediated Tau Phosphorylation
por: Hanger, Diane P., et al.
Publicado: (2011)

Emerging Roles of Glycogen Synthase Kinase 3 in the Treatment of Brain Tumors
por: Mills, Caroline N., et al.
Publicado: (2011)

Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)
por: LI, DA-WEI, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pg3r8gmjh4ckcmov5rdf3t9l53